⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4017458 | 0.97 | EPHX1 (0.67) | — | |
| SCHEMBL529370 | 0.97 | EPHX1 (0.67) | — | |
| SCHEMBL740145 | 0.97 | EPHX1 (0.67) | — | |
| Hydrochloric Acid SCHEMBL28662905 | 0.97 | EPHX1 (0.59) | — | |
| SCHEMBL4017465 | 0.97 | EPHX1 (0.67) | — | |
| SCHEMBL28034199 | 0.97 | EPHX1 (0.67) | — | |
| Hydrochloric Acid SCHEMBL11512953 | 0.95 | EPHX1 (0.64) | — | |
| Bromide SCHEMBL31210076 | 0.95 | EPHX1 (0.64) | — | |
| Hydrochloric Acid SCHEMBL11155165 | 0.95 | EPHX1 (0.64) | — | |
| SCHEMBL897214 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 502 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3715346-B1 | THIAZOLYL-CONTAINING COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | DANA FARBER CANCER INST INC (US) | 2024-01-03 | — | — | EP | claimed |
| CN-117177979-A | Cyclic dibenzyl tetrahydroisoquinoline compound and preparation method and application thereof | 中国科学院上海药物研究所 | 2023-12-05 | — | — | CN | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| CN-112708055-B | Ester-ether copolymerization viscosity reduction type hydration regulator and preparation method thereof | 科之杰新材料集团(贵州)有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-112708053-B | Ester viscosity-reducing hydration regulator and preparation method thereof | 科之杰新材料集团有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-112708052-B | Ether viscosity-reducing hydration regulator and preparation method thereof | 科之杰新材料集团(贵州)有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-112708056-B | Viscosity-reducing polycarboxylate superplasticizer for concrete member and preparation method thereof | 科之杰新材料集团河南有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-112708054-B | Polycarboxylate superplasticizer for concrete member and preparation method thereof | 科之杰新材料集团河南有限公司 | 2022-10-18 | — | — | CN | claimed |
| EP-3291676-B1 | MITRAGYNINE ANALOGS AND USES THEREOF | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-08-17 | — | — | EP | claimed |
| WO-2022154356-A1 | COMPOSITION COMPRISING (7S)-(+)-CYCLOPENTYL CARBARMIC ACID, 8,8-DIMETHYL-2-OXO-6,7-DIHYDRO-2H,8H-PYRANO[3,2-G]CHROMEN-7-YL-ESTER AS ACTIVE INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF EYE DISEASE | 국민대학교 산학협력단 | 2022-07-21 | — | — | WO | claimed |
| US-20090082399-A1 | Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors | ADDEX PHARMA SA (CH) | 2009-03-26 | — | — | US | claimed |
| EP-1799673-A1 | PYRAZOLE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS | Memory Pharmaceuticals Corporation (US) | 2007-06-27 | — | — | EP | claimed |
| JP-2007504271-A | — | — | 2007-03-01 | — | — | JP | claimed |
| CN-1898234-A | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | INCYTE CORP (US) | 2007-01-17 | — | — | CN | claimed |
| CN-1878773-A | Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands | NEUROGEN CORP (US) | 2006-12-13 | — | — | CN | claimed |
| EP-1680424-A2 | HETEROARYL FUSED PYRIDINES, PYRAZINES AND PYRIMIDINES AS CRF1 RECEPTOR LIGANDS | Neurogen Corporation (US) | 2006-07-19 | — | — | EP | claimed |
| US-20060154960-A1 | Phosphodiesterase 4 inhibitors | MEMORY PHARMACEUTICALS CORPORATION | 2006-07-13 | — | — | US | claimed |
| WO-2006044528-A1 | PYRAZOLE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS | MEMORY PHARMACEUTICALS CORPORATION (US) | 2006-04-27 | — | — | WO | claimed |
| US-20050113379-A1 | Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands | AVENTIS PHARMACEUTICALS, INC. | 2005-05-26 | — | — | US | claimed |
| WO-2005023806-A2 | HETEROARYL FUSED PYRIDINES, PYRAZINES AND PYRIMIDINES AS CRF1 RECEPTOR LIGANDS | NEUROGEN CORPORATION (US) | 2005-03-17 | — | — | WO | claimed |